City of Hope's Tycel Phillips, M.D., discusses the promising results from a Phase I/II study on glofitamab for treating relapsed/refractory mantle cell lymphoma. Dr. Phillips presented findings at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
#lymphoma #lymphomaresearch #asco24
Want to learn more about City of Hope’s impact on cancer?
Subscribe to the City of Hope KZread Channel: kzread.info/dron/tyo.html...
Visit our Website: www.cityofhope.org/
Call us at: 626-256-HOPE (4673)
Stay connected with us on social media:
► Facebook: / cityofhope
► X: / cityofhope
► Instagram: / cityofhope
► LinkedIn: / city-of-hope